About
Basic Data Updated:
2 months agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540359.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 cr and a paid-up capital of Rs 3.74 cr.
The Corporate currently has active open charges totaling ₹6.72 cr. It has already closed loans amounting to ₹8.24 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Parmax Pharma Limited India is Keyur Vora as Cfo. Nikhil Uchat, Ami Rajeshbhai, and Umang Gosalia serve as directors at the Company.
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L24231GJ1994PLC023504 |
| Company No. | 023504 |
| Stock Symbol | BSE : 540359 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 02 Nov 1994 |
| Date of AGM | 29 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Ahmedabad |
Financials of Parmax Pharma Limited
Parmax Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.56% decrease. The company also saw a substantial fall in profitability, with a 173.54% decrease in profit. The company's net worth dipped by a decrease of 1.75%.
Corporate Structure
Unlock access to Parmax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Parmax Pharma Limited
Unlock and access historical data on people associated with Parmax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
Umang Gosalia
Managing DirectorAppointment Date: 02-Jan-2016
Status: Current
KV
Keyur Vora CFOAppointment Date: 02-Jan-2016
Status: Current
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2023 | ₹6.72 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Feb 2019 | ₹1.12 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 16 Oct 2018 | ₹6.85 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parmax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
20 years 6 months Recent activity within the organization
Charges
A charge with Others of Rs. 6.72 cr registered on 31 May 2023 with Charge ID 100775935 was modified on 10 Nov 2023.
10 Nov 2023Charges
A charge registered on 08 Feb 2019 via Charge ID 100240259 with Hdfc Bank Limited was fully satisfied on 16 Oct 2023.
16 Oct 2023Charges
A charge registered on 16 Oct 2018 via Charge ID 100215130 with Hdfc Bank Limited was fully satisfied on 16 Oct 2023.
16 Oct 2023Annual General Meeting
Parmax Pharma Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Charges
A charge with Others amounted to Rs. 6.72 cr with Charge ID 100775935 was registered on 31 May 2023.
31 May 2023
Recent News, Updates & Announcement
Parmax Pharmas Quarterly Numbers Show Impressive Growth in Sales Profits EBITDA and EPS Stock Price on the Rise.Parmax Pharmas quarterly numbers are looking good with a big increase in sales and profits EBITDA is also up by a crazy amount EPS has gone up too Their stock price has gone up a bit but its still down from last year Overall things are looking up for Parmax Pharma winning pharmalife.
Moneycontrol 12 Feb 2023
- Board of Parmax Pharma appoints director and approves expansion of plant.
Business Standard 20 Jun 2018
Frequently asked questions
What is the Incorporation or founding date of Parmax Pharma Limited?
